@article{deledinghen:hal-01743768,
TITLE = {Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study},
AUTHOR = {de Ledinghen, Victor and Laforest, Claire and Hezode, Christophe and Pol, Stanislas and Renault, Alain and Alric, Laurent and Larrey, Dominique and M{\'e}tivier, Sophie and Tran, Albert and J{\'e}z{\'e}quel, Caroline and Samuel, Didier and Zoulim, Fabien and Tual, Christelle and Pailh{\'e},
Aur{\'e}lie and Gibowski, S{\'e}verine and Bourli{\`e}re, Marc and Bellissant, Eric and Pawlotsky, Jean-Michel},
URL = {https://univ-rennes.hal.science/hal-01743768},
JOURNAL = {Infectious Diseases in Clinical Practice},
PUBLISHER = {Lippincott, Williams \& Wilkins},
VOLUME = {66},
NUMBER = {7},
PAGES = {1013-1018},
YEAR = {2018},
MONTH = Mar, DOI = {10.1093/cid/cix916},
KEYWORDS = {grazoprevir/elbasvir ; sofosbuvir ; hepatitis C ; RAS ; DAA},
PDF = {https://univ-rennes.hal.science/hal-01743768/file/Retreatment%20with%20sofosbuvir%20plus%20grazoprevir_accepted.pdf},
HAL_ID = {hal-01743768},
HAL_VERSION = {v1},
}